October 19, 2004
Nonapprovable letter to Allergan
The FDA has issued a nonapprovable letter to Allergan for tazarotene capsules (oral tazarotene) for the treatment of psoriasis.
Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).
Brands should refrain from tweets that are over 100 characters, according to Twitter's director of brand strategy.